Идёт набор NCT05477563
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Beta-Thalassemia · Thalassemia · Hematologic Diseases
Гематология
3 640 исследований в этом разделе
Идёт набор NCT04998669
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Follicular Lymphoma
Идёт набор NCT07487428
CLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage CLL
CLL (Chronic Lymphocytic Leukemia)
Идёт набор NCT01408225
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Plasma Cell Dyscrasias · Monoclonal Gammopathy of Undetermined Significance · AL Amyloidosis
Идёт набор NCT07096297
Luspatercept + Darbepoetin in MDS
MDS (Myelodysplastic Syndrome)
Набор скоро начнётся NCT05969821
Clonal Hematopoiesis of Immunological Significance
Immune System Diseases · Autoimmune Diseases · Inflammation
Идёт набор NCT04990102
Phase IB/II of CPX-351 for Relapse Prevention in AML
Acute Myeloid Leukemia (AML) in Remission
Идёт набор NCT04742634
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
Myelodysplastic Syndromes
Набор скоро начнётся NCT07486479
Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML
Acute Myeloid Leukemia (AML)
Набор скоро начнётся NCT07354555
Multiple Myeloma Extramedulary Disease Samples FFPE
Multiple Myeloma Survival Outcome · Multiple Myeloma and Malignant Plasma Cell Neoplasms
Идёт набор NCT05595577
Improving Exercise Capacity With a Tailored Physical Activity Intervention
Non Hodgkin Lymphoma · Heart; Functional Disturbance · Hodgkin Lymphoma
Идёт набор NCT07463651
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Acute Myeloid Leukemia (AML) · FLT3-ITD Mutation · Allogeneic Hematopoietic Cell Transplantation (HCT)
Идёт набор NCT07380984
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
Natural Killer/T-cell Lymphoma
Набор скоро начнётся NCT07485504
Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies
Relapsed or Refractory Hematologic Malignancies
Набор скоро начнётся NCT07485647
Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing
Multiple Myeloma
Идёт набор NCT04830137
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Waldenstrom Macroglobulinemia (WM)
Набор скоро начнётся NCT07486726
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) · Relapse Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia (AML)
Идёт набор NCT06220162
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
Acute Myeloid Leukemia
Идёт набор NCT05376111
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
T-cell Acute Lymphoblastic Leukemia · Recruiting
Идёт набор NCT06563245
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Classical Hodgkin Lymphoma · Child · Adolescent
Идёт набор NCT06440135
Ziftomenib Maintenance Post Allo-HCT
Acute Myeloid Leukemia · Acute Myeloid Leukemia in Remission · NPM1 Mutation
Идёт набор NCT05796570
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
Acute Myeloid Leukemia · Myelodysplastic Syndromes · Myeloid Malignancies
Идёт набор NCT05681260
Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)
T-cell Lymphoblastic Lymphoma
Идёт набор NCT07481669
ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse
Lymphoma Patients With High-risk of Central Nervous System Relapse
Набор скоро начнётся NCT07482761
Multiple Myeloma t(4 ;14) FFPE Samples
Multiple Myeloma and Malignant Plasma Cell Neoplasms
Идёт набор NCT05306509
Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology
Solid Tumor · Hematological Malignancies
Идёт набор NCT06379360
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
Acute Myeloid Leukemia
Набор скоро начнётся NCT07483476
Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia ALL
Набор скоро начнётся NCT07483749
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Lymphoma
Идёт набор NCT06207123
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
Acute Leukemia · Lymphoblastic Leukemia · Lymphoblastic Lymphoma
Идёт набор NCT07270770
BY002 IIT Study in R/R Acute Leukemia
Acute Leukemia · KMT2A Rearrangements or NPM1 Mutations Acute Leukemia
Идёт набор NCT05636514
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
Myelodysplastic Syndromes · Chronic Myelomonocytic Leukemia · Acute Myeloid Leukemia
Идёт набор NCT04546945
Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
Hematologic Malignancies
Идёт набор NCT06153251
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Идёт набор NCT05272826
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients
Multiple Myeloma
Идёт набор NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Mixed Lineage Acute Leukemia
Набор скоро начнётся NCT07476066
Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma
Relapsed/Refractory Aggressive B-Cell Lymphoma
Идёт набор NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Acute Lymphoblastic Leukemia (ALL)
Идёт набор NCT06859424
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
AML (Acute Myelogenous Leukemia) · Acute Lymphoid Leukemia (ALL) · Acute Leukemia (Category)
Набор скоро начнётся NCT07477366
Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma
Relapsed B-Cell Non-Hodgkin Lymphoma
Набор скоро начнётся NCT07476378
A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies
Lymphoma, Large B-Cell, Diffuse (DLBCL) · Lymphoma, Follicular · Lymphoma, Mantle-Cell
Идёт набор NCT06418204
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma · Colorectal Carcinoma · Lung Non-Small Cell Carcinoma
Набор скоро начнётся NCT07476885
A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases
Drug-Induced Liver Injury
Идёт набор NCT06918431
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · Lymphoblastic Lymphoma
Идёт набор NCT06994676
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
High-risk Myelodysplastic Syndrome · Chronic Myelomonocytic Leukemia (CMML) · AML - Acute Myeloid Leukemia
Идёт набор NCT05294367
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
Lymphoma
Идёт набор NCT06960382
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
Allergic Rhinitis · Allergic Asthma
Идёт набор NCT07473167
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
Relapsed Large B-cell Lymphoma · Refractory Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma (DLBCL)
Идёт набор NCT04282187
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Acute Myeloid Leukemia · Essential Thrombocythemia · Myelodysplastic Syndrome
Идёт набор NCT07283900
Ascorbate in Myelodysplastic Syndrome
Myelodysplastic Syndromes
Набор скоро начнётся NCT07474961
BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
Waldenstrom Macroglobulinaemia · Multiple Myeloma
Набор скоро начнётся NCT07472621
Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma
DLBCL - Diffuse Large B Cell Lymphoma
Идёт набор NCT03838926
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Relapsed or Refractory Hematologic Malignancies
Идёт набор NCT05011422
Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies
Pediatric Hematologic Malignancies
Идёт набор NCT06442475
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
Ann Arbor Stage II Follicular Lymphoma · Ann Arbor Stage II Marginal Zone Lymphoma · Ann Arbor Stage III Follicular Lymphoma
Идёт набор NCT05735184
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Acute Myeloid Leukemia · Mixed Lineage Leukemia Gene Mutation · Refractory AML
Идёт набор NCT06348108
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Multiple Myeloma · Refractory Multiple Myeloma · Relapsed Multiple Myeloma
Идёт набор NCT06557421
De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
Acute Myeloid Leukemia
Идёт набор NCT06523556
Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Atypical Chronic Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myelodysplastic/Myeloproliferative Neoplasm
Идёт набор NCT07470996
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR
Peripheral T Cell Lymphoma
Идёт набор NCT06138275
Elranatamab in R/R Multiple Myeloma
Refractory Multiple Myeloma · Relapse Multiple Myeloma · Multiple Myeloma
Идёт набор NCT06510309
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
Lymphoma · Marginal Zone Lymphoma · MZL
Идёт набор NCT07128641
Odronextamab in Low Tumor Volume Advanced FL
Follicular Lymphoma · Lymphoma
Идёт набор NCT06055621
Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE
Acute Myeloid Leukemia
Идёт набор NCT06510361
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Lymphoma · Follicular Lymphoma · Lymphoma,Non-Hodgkin
Идёт набор NCT07218510
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Идёт набор NCT06572618
Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
Mantle Cell Lymphoma
Идёт набор NCT06840756
Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes
Red Blood Cell Transfusions · Sex Differences · Health Services
Идёт набор NCT05292664
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Myelodysplastic Syndromes, de Novo · Myelodysplastic Syndromes, Secondary · Myelodysplastic Syndromes, Previously Treated
Идёт набор NCT05627232
Tazemetostat and Palbociclib With CPX-351for R/R AML
Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia
Набор по приглашению NCT05332054
Long-Term Follow-up Study
Lymphoma, Non-Hodgkin · Relapsed Non-Hodgkin Lymphoma · Refractory B-Cell Non-Hodgkin Lymphoma
Идёт набор NCT06832865
ELISA in Relapsed/Refractory MM
Relapsed Refractory Multiple Myeloma (RRMM) · Relapsed Refractory Multiple Myeloma
Идёт набор NCT06142396
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
Multiple Myeloma · Renal Failure
Идёт набор NCT03970096
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia
Идёт набор NCT05679895
Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL
T-cell Acute Lymphoblastic Leukemia · Lymphoblastic T-Cell Lymphoma
Идёт набор NCT06976476
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Multiple Myeloma · Hypogammaglobulinemia · Hypogammaglobulinemia, Acquired
Идёт набор NCT03471260
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Acute Myeloid Leukemia · Hematopoietic and Lymphoid System Neoplasm · Myelodysplastic Syndrome
Набор скоро начнётся NCT07463768
Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.
Acute Myeloid Leukemia
Набор скоро начнётся NCT07372885
GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia
Acute Myeloid Leukemia · Stem Cell Transplantation · Stem Cell Transplantation, Hematopoietic
Идёт набор NCT05896228
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
Refractory Multiple Myeloma · Relapsed Multiple Myeloma
Идёт набор NCT07463989
National Epidemiology of Cutaneous Lymphomas
Lymphoma With Cutaneous Involvement
Идёт набор NCT06229860
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
Chronic Myeloid Leukemia · Chronic Phase Chronic Myelogenous Leukemia
Идёт набор NCT05256641
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma · High-grade B-cell Lymphoma · Transformed Lymphoma
Идёт набор NCT06890494
Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia
Leukemia
Набор скоро начнётся NCT07462299
NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy
Childhood Acute Lymphoblastic Leukemia
Идёт набор NCT07460362
Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma
MCL · Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Идёт набор NCT05748197
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Acute Myeloid Leukemia
Набор скоро начнётся NCT07461142
Reduction of Hematologic Toxicity in Locally Advanced Cervical Cancers
Cervical Cancer by FIGO Stage 2018
Идёт набор NCT07461116
Adverse Effects of ATG/ALG Therapy in Aplastic Anemia
Aplastic Anaemia
Идёт набор NCT06059391
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Lymphocytic Leukemia
Идёт набор NCT06343090
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
B-cell Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia, in Relapse · Refractory Acute Lymphoid Leukemia
Набор по приглашению NCT06645093
Feasibility of Intermittent Fasting During Chemotherapy
Lymphoma · Cancer · Fasting
Набор скоро начнётся NCT07457177
Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL
NK T-Cell Lymphoma
Идёт набор NCT01746836
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive · Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia · Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Идёт набор NCT06548230
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Myelodysplastic Syndrome(MDS) · Acute Myelogenous Leukemia (AML)
Идёт набор NCT04304820
Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
Severe Aplastic Anemia
Идёт набор NCT06627309
Rapid dFLC Response Predict CHR in AL Amyloidosis
Systemic AL Amyloidosis
Идёт набор NCT06569147
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
AL Amyloidosis
Идёт набор NCT06375044
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Набор скоро начнётся NCT07060001
Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
Acute Myeloid Leukemia (AML) · Acute Myeloid Leukaemia (AML)